Literature DB >> 27264777

Management of chronic obstructive pulmonary disease beyond the lungs.

Lowie E G W Vanfleteren1, Martijn A Spruit2, Emiel F M Wouters3, Frits M E Franssen3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is an umbrella term that covers many clinical subtypes with clearly different pulmonary and extra-pulmonary characteristics, but with persistent airflow limitation in common. This insight has led to the development of a more personalised approach in bronchodilator therapy, prevention of exacerbations, and advanced treatments (such as non-invasive ventilation and lung volume reduction techniques). However, systemic manifestations and comorbidities of COPD also contribute to different clinical phenotypes and warrant an individualised approach as part of integrated disease management. Alterations in bodyweight and composition, from cachexia to obesity, demand specific management. Psychological symptoms are highly prevalent, and thorough diagnosis and treatment are necessary. Moreover, prevention of exacerbations requires interventions beyond the lungs, including treatment of gastro-oesophageal reflux disease, reduction of cardiovascular risks, and management of dyspnoea and anxiety. In this Review, we discuss the management of COPD beyond the respiratory system and propose treatment strategies on the basis of the latest research and best practices.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27264777     DOI: 10.1016/S2213-2600(16)00097-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  46 in total

Review 1.  Sarcopenia and frailty in chronic respiratory disease.

Authors:  Anna E Bone; Nilay Hepgul; Samantha Kon; Matthew Maddocks
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

2.  High Rates of Premature and Potentially Preventable Death among Patients Surviving Melioidosis in Tropical Australia.

Authors:  Josh Hanson; Simon Smith
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

3.  Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling.

Authors:  Karim H Shalaby; Miranda R Lyons-Cohen; Gregory S Whitehead; Seddon Y Thomas; Immo Prinz; Hideki Nakano; Donald N Cook
Journal:  J Allergy Clin Immunol       Date:  2017-11-14       Impact factor: 10.793

Review 4.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

5.  Body mass index of patients with chronic obstructive pulmonary disease is associated with pulmonary function and exacerbations: a retrospective real world research.

Authors:  Zhenchao Wu; Dong Yang; Zhengwei Ge; Mengdie Yan; Nan Wu; Yi Liu
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  The efficacy of manual therapy for chronic obstructive pulmonary disease: A systematic review.

Authors:  Ji-Ae Roh; Kwan-Il Kim; Hee-Jae Jung
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

7.  Adherence to a COPD treatment guideline among patients in Hong Kong.

Authors:  Ka Pang Chan; Fanny Ws Ko; Hok Sum Chan; Mo Lin Wong; Thomas Yw Mok; Kah Lin Choo; David Sc Hui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-28

8.  Adherence to an eHealth Self-Management Intervention for Patients with Both COPD and Heart Failure: Results of a Pilot Study.

Authors:  Joanne Sloots; Mirthe Bakker; Job van der Palen; Michiel Eijsvogel; Paul van der Valk; Gerard Linssen; Clara van Ommeren; Martijn Grinovero; Monique Tabak; Tanja Effing; Anke Lenferink
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-07-15

Review 9.  Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.

Authors:  Marc Miravitlles; Nicolas Roche; João Cardoso; David Halpin; Zaurbek Aisanov; Hannu Kankaanranta; Vladimir Kobližek; Paweł Śliwiński; Leif Bjermer; Michael Tamm; Francesco Blasi; Claus F Vogelmeier
Journal:  Respir Res       Date:  2018-01-18

10.  Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.

Authors:  Netsanet A Negewo; Peter G Gibson; Peter Ab Wark; Jodie L Simpson; Vanessa M McDonald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.